ライト・ストラテジー
Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q3 | -3.56 | $0 | -$2M |
| 2025 Q2 | -4.62 | $0 | -$2M |
| 2025 Q1 | -0.55 | $0 | -$5M |
| 2025 Q4 | -0.40 | $0 | -$2M |
| 2025 Q3 | -0.39 | $0 | -$3M |
| 2024 Q2 | -0.40 | $0 | — |
| 2024 Q1 |
| -1.20 |
| $0 |
| -$11M |
| 2024 Q4 | -2.76 | $0 | -$18M |